Back

Clinical actionability of genetic findings in cerebral palsy

2023-09-11 genetic and genomic medicine Title + abstract only
View on medRxiv
Show abstract

Background and objectivesSingle gene mutations are increasingly recognized as causes of cerebral palsy (CP) phenotypes, yet there is currently no standardized framework for measuring their clinical impact. We evaluated Pathogenic/Likely Pathogenic (P/LP) variants identified in individuals with CP to determine how frequently genetic testing results would prompt changes in care. MethodsWe analyzed published P/LP variants in OMIM genes identified in clinical (n = 1,345 individuals) or research (n ...

Predicted journal destinations